Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data.

Abstract

These findings demonstrate the importance of complete analysis of FasL expression by tumor cells in order to fully characterize its biological function and may help to resolve the discrepancies present in the literature regarding FasL expression and tumor immune privilege.